2nd Circuit

  • Circus Clashes with Cosmetic Co.

    Ringling Bros. and Barnum & Bailey circus has a bone to pick with Sephora over the cosmetic giant's circus-themed marketing campaign. On Nov. 28 Ringling brought suit against Sephora in the U.S. District Court for the Southern District of New York alleging the company infringed its popular "The Greatest Show...

  • FCC Indecency Rules Go Back to the Drawing Board

    Broadcasters pose challenge to agency's authority.

  • New York Grants Transgender Rights

    New York State Supreme Court found transgendered people are protected under the same laws that outlaw religious and racial discrimination.

  • Gun Dealer Shoots Back at N.Y. Mayor

    Adventure Outdoors filed suit against New York City Mayor Michael Bloomberg alleging he defamed the company when he named it in his recent lawsuit against 15 gun retailers.

  • Insurers Settle With Purdue Pharma

    Steadfast filed suit against Purdue claiming that Purdue's liability insurance coverage had been exhausted and it shouldn't have to pay claims related to attorneys that Purdue hired without consulting the insurer.

  • Nine West Settles Origin Bias Suit

    Nine West Footwear Corp. and Jones Apparel Group Inc. reached a $600,000 settlement with the EEOC ending a 2004 suit accusing the shoe companies of sexual harassment, national origin discrimination and retaliation.

  • Workers Sue C&S for Overtime Pay

    A group workers have filed a class action against C&S Wholesale Grocers Inc. for violations of labor laws.

  • Pfizer Faces Off-Label Suit

    A suit filed against Pfizer claims the company's off-label promotion of its drug Lipitor caused them to pay billions of dollars in unwarranted prescriptions.

  • Browns Score Patent Victory

    On Feb. 14, the U.S. District Court for the Southern District of New York ruled that the NFLP is the senior user of the "Dawg Pound" phrase.

  • Courts Interpret Securities Law in Wake of Dura

    Most of the defense bar applauded the Supreme Court's April 2005 decision in Dura Pharmaceuticals Inc. v. Broudo because it significantly tightened the reins on securities fraud cases. Dura rejected the notion that simply alleging the stock price was inflated at the time of purchase due to misrepresentation gives rise...

Advertisement. Closing in 15 seconds.